Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
News + Filings
Transactions
Bozic Carmen
Date
Name
Symbol
Type
Security
Shares
Price
Value
Ownership
Reported
10/03/2023
VERTEX PHARMACEUTICALS INC / MA
VRTX
Sale
Common Stock
5.7k
$345.28
$2M
10/03/2023
02/17/2023
VERTEX PHARMACEUTICALS INC / MA
VRTX
Payment of Exercise
Common Stock
3.8k
$292.85
$1.1M
02/17/2023
02/13/2023
VERTEX PHARMACEUTICALS INC / MA
VRTX
Payment of Exercise
Common Stock
5k
$298.26
$1.5M
02/10/2023
02/10/2023
VERTEX PHARMACEUTICALS INC / MA
VRTX
Payment of Exercise
Common Stock
2.7k
$294.33
$796.8k
02/10/2023
05/31/2022
VERTEX PHARMACEUTICALS INC / MA
VRTX
Payment of Exercise
Common Stock
311
$271.24
$84.4k
05/31/2022
02/24/2022
VERTEX PHARMACEUTICALS INC / MA
VRTX
Payment of Exercise
Common Stock
1.2k
$227.86
$283k
02/24/2022
02/17/2022
VERTEX PHARMACEUTICALS INC / MA
VRTX
Payment of Exercise
Common Stock
3.4k
$232.51
$799.6k
02/17/2022
02/10/2022
VERTEX PHARMACEUTICALS INC / MA
VRTX
Payment of Exercise
Common Stock
2.4k
$237.74
$579.4k
02/10/2022
05/28/2021
VERTEX PHARMACEUTICALS INC / MA
VRTX
Payment of Exercise
Common Stock
311
$210.04
$65.3k
05/28/2021
02/24/2021
VERTEX PHARMACEUTICALS INC / MA
VRTX
Payment of Exercise
Common Stock
311
$217.57
$67.7k
02/24/2021
02/10/2021
VERTEX PHARMACEUTICALS INC / MA
VRTX
Payment of Exercise
Common Stock
2.4k
$214.16
$506.9k
02/10/2021
02/03/2021
VERTEX PHARMACEUTICALS INC / MA
VRTX
Grant
Common Stock
11.6k
$0.00
$0
02/03/2021
02/03/2021
VERTEX PHARMACEUTICALS INC / MA
VRTX
Grant
Common Stock
10.3k
$0.00
$0
02/03/2021
05/29/2020
VERTEX PHARMACEUTICALS INC / MA
VRTX
Payment of Exercise
Common Stock
311
$282.74
$87.9k
05/29/2020
02/24/2020
VERTEX PHARMACEUTICALS INC / MA
VRTX
Payment of Exercise
Common Stock
216
$239.23
$51.7k
02/24/2020
02/05/2020
VERTEX PHARMACEUTICALS INC / MA
VRTX
Grant
Common Stock
10.3k
$0.00
$0
02/05/2020
02/05/2020
VERTEX PHARMACEUTICALS INC / MA
VRTX
Grant
Common Stock
2.1k
$0.00
$0
02/05/2020
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy